358 related articles for article (PubMed ID: 35087972)
1. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
2. Neovascular Glaucoma: An Update.
Kalogeropoulos D; Moussa G; Sung VC; Pappa C; Kalogeropoulos C
Klin Monbl Augenheilkd; 2023 Mar; 240(3):305-315. PubMed ID: 36436509
[TBL] [Abstract][Full Text] [Related]
3. Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure.
Senthil S; Chary R; Ali MH; Cherukuri JR; Rani PK; Krishnamurthy R; Choudhari N; Garudadri C
Indian J Ophthalmol; 2021 Nov; 69(11):3341-3348. PubMed ID: 34708802
[TBL] [Abstract][Full Text] [Related]
4. Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization.
Sun C; Zhang H; Tang Y; Chen Y; Li Y; Nie C; Gu J; Luo L; Wang Z
Curr Eye Res; 2020 Dec; 45(12):1504-1513. PubMed ID: 32339463
[No Abstract] [Full Text] [Related]
5. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.
Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical outcomes of raised intraocular pressure following intravitreal triamcinolone acetonide injection.
Singh P; Krishnaprasad R; Ayachit G; Joshi S
Rom J Ophthalmol; 2024; 68(1):37-44. PubMed ID: 38617725
[No Abstract] [Full Text] [Related]
7. Neovascular glaucoma - A review.
Senthil S; Dada T; Das T; Kaushik S; Puthuran GV; Philip R; Rani PK; Rao H; Singla S; Vijaya L
Indian J Ophthalmol; 2021 Mar; 69(3):525-534. PubMed ID: 33595466
[TBL] [Abstract][Full Text] [Related]
8. A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.
Urbonavičiūtė D; Buteikienė D; Janulevičienė I
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557072
[TBL] [Abstract][Full Text] [Related]
9. Neovascular Glaucoma from Ocular Ischemic Syndrome Treated with Serial Monthly Intravitreal Bevacizumab and Panretinal Photocoagulation: A Case Report.
Asif H; Si Z; Quan S; Amin P; Dao D; Shaw L; Skondra D; Qiu M
Case Rep Ophthalmol Med; 2022; 2022():4959522. PubMed ID: 35935916
[TBL] [Abstract][Full Text] [Related]
10. Neovascular Glaucoma.
Havens SJ; Gulati V
Dev Ophthalmol; 2016; 55():196-204. PubMed ID: 26501989
[TBL] [Abstract][Full Text] [Related]
11. Gonioscopy-assisted transluminal trabeculotomy in neovascular glaucoma: Salvaging the conventional outflow pathway.
Kanter JA; Amin P; Komati R; Mackin AG; Dao D; Shaw LT; Skondra D; Qiu M
Am J Ophthalmol Case Rep; 2022 Dec; 28():101668. PubMed ID: 36051187
[TBL] [Abstract][Full Text] [Related]
12. Widefield swept-source optical coherence tomography angiography metrics associated with neovascular glaucoma in patients with proliferative diabetic retinopathy.
Lu ES; Cui Y; Le R; Zhu Y; Wang JC; Laíns I; Katz R; Lu Y; Zeng R; Garg I; Wu DM; Husain D; Kim LA; Miller JB
Graefes Arch Clin Exp Ophthalmol; 2024 Apr; 262(4):1111-1120. PubMed ID: 37962666
[TBL] [Abstract][Full Text] [Related]
13. Neovascular glaucoma: a review.
Rodrigues GB; Abe RY; Zangalli C; Sodre SL; Donini FA; Costa DC; Leite A; Felix JP; Torigoe M; Diniz-Filho A; de Almeida HG
Int J Retina Vitreous; 2016; 2():26. PubMed ID: 27895936
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
[TBL] [Abstract][Full Text] [Related]
15. The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy.
Tang Y; Shi Y; Fan Z
Front Endocrinol (Lausanne); 2023; 14():1102361. PubMed ID: 36755912
[TBL] [Abstract][Full Text] [Related]
16. Ischemic index and distribution of retinal capillary non-perfusion in neovascular glaucoma.
DeBoer C; Wong B; Ameri H
Front Biosci (Landmark Ed); 2022 Jan; 27(1):24. PubMed ID: 35090329
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor for neovascular glaucoma.
Simha A; Aziz K; Braganza A; Abraham L; Samuel P; Lindsley KB
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD007920. PubMed ID: 32027392
[TBL] [Abstract][Full Text] [Related]
18. The pathological association between the anterior eye segment and the retina in a murine model of neovascular glaucoma.
Nishinaka A; Tanaka M; Aoshima K; Kuriyama A; Sasaki T; Otsu W; Yasuda H; Nakamura S; Shimazawa M; Hara H
FASEB J; 2022 Jun; 36(6):e22323. PubMed ID: 35485981
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.
Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
